Even a model trained on PubMed, clinical guidelines, biomedical literature, or real-world data still produces probabilistic inferences. It can be useful, powerful, even extraordinary. But its output alone is not yet reliable clinical knowledge in any strong sense.
In high-risk domains, a plausible prediction is not enough. A confidence score is not enough. Even excellent average accuracy is not enough. Because the real patient is not a statistical average: they are a specific case, with comorbidities, missing variables, interactions, exceptions, contraindications, and context.
The real innovation is not saying "less AI." The real innovation is building a deterministic layer of verification, falsification, and admissibility on top of the model's probabilistic inference.
AI can generate diagnostic hypotheses, clinical priorities, therapeutic recommendations. But their entry into the decision-making process must be subordinated to a framework that verifies, in a traceable and repeatable way: internal consistency, adherence to applicable guidelines, presence of contraindication checks, availability of supporting evidence.
The focus is no longer just prediction, but admissibility.
No longer just "what does the model suggest?", but: "under what conditions can this inference be considered clinically usable?"
What is needed is an architecture where the model generates, the deterministic layer verifies and falsifies, and the clinical process decides based on structured evidence.
I had already formalized this principle for AI-generated software, where the model's output is not treated as truth but as a hypothesis subjected to a deterministic verification pipeline. If this is necessary for software, how much more urgent is it for medicine?
AI in medicine should not be slowed down. It should be made epistemically sound.
The future is AI subjected to rigorous conditions of verifiability, falsifiability, and clinical admissibility, in contexts where an error can cost a person's health.